Grifols (GRFS) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2025)
Grifols (GRFS) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 7.44% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 9.71% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.99% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 20.68% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 5.25% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 24.68% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 6.85% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 1.35% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 3.22% |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | 1.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -78.32% |
| Dec 31, 2024 | 7,658.25% |
| Dec 31, 2023 | -101.31% |
| Dec 31, 2022 | 479.01% |
| Dec 31, 2021 | 5.17% |
| Dec 31, 2020 | 15.92% |
| Sep 30, 2020 | 8.02% |
| Mar 31, 2020 | 7.56% |
| Dec 31, 2019 | 7.29% |
| Sep 30, 2019 | 8.15% |
| Mar 31, 2019 | 6.81% |
| Dec 31, 2018 | 7.51% |
| Jun 30, 2018 | 11.19% |
| Dec 31, 2017 | 6.05% |
| Jun 30, 2017 | 4.12% |
| Dec 31, 2016 | 8.42% |
| Sep 30, 2016 | 6.57% |
| Dec 31, 2015 | 25.65% |
| Sep 30, 2015 | 23.03% |
| Mar 31, 2015 | 37.87% |